Elypta
Developer a metabolism-based liquid biopsy platform designed to prevent cancer mortality through earlier detection and closer monitoring. The company's platform utilizes assay technology for comprehen...
Valuation
$0
Share Price
N/A
Total Raised
$29.8M
Last Round
N/A